Stem cells Expertise and services
Our technology center assists investigators in performing innovative research, ranging from molecules to man. It connects a broad range of research groups that have expertise in different stem cell fields with a focus on human induced Pluripotent Stem Cell (iPSC) technology.read more
Stem cells Expertise and servicesThe Radboudumc Stem Cell Technology Center assists investigators in performing innovative research, ranging from molecules to man. It connects a broad range of research groups that have expertise in different stem cell fields with a focus on human induced Pluripotent Stem Cell (iPSC) technology. This provides a state-of-the-art service to reprogram different cell types into iPSCs that enable the development of an unlimited source of any type of human cell needed for study or therapeutic purposes.
- To generate experimentally validated human iPSCs: reprogrammed iPSCs are analysed for their stemness by quantitative reverse transcription and immunocytochemistry, and the characterisation can be extended to genomic integrity and differentiation capacities into the three germ layers.
- iPSC culture training and consultancy
- Consultancy of iPSC differentiation methods
- Consultancy on other stem cell cultures: human haematopoietic stem cells, human epidermal stem cells, human organoids, mouse embryonic stem cells (serum and 2i conditions)
- Joint expertise in different research fields: cell biology, genomics and epigenomics.
- Research projects based on collaboration
Areas of expertise
- Different stem cell fields with a focus on human iPSC technology
- Tissue regeneration
- Lentiviral transduction of human fibroblasts with pluripotency transcription factors to generate iPSCs
- Episomal nucleofection of several cell types for iPSC generation
- iPSCs pluripotency analysis by quantitative reverse transcription and immunocytochemistry
Application of stem cell technologyiPSCs can be used to study disease mechanisms. For example, patient-derived iPSCs can be differentiated into cells, tissues and organs that are normally not available from patients, to identify genetic (e.g. at the mRNA level) and cellular defects in patients. They also provide a platform for developing therapeutic approaches, such as drug screening, gene correction and cell-based strategies, for an individual or a large number of patients.
- Stem Cell Applications
- Fundamental studies of development
- Genetic studies of diseases
- Disease modelling
- Drug screening
- Regenerative medicine